neoplasm
|
• 24 of 30 mutants develop pancreatic ductal adenocarcinomas
|
mortality/aging
|
• average survival time is 168 days, with a range of 60-254 days
|
endocrine/exocrine glands
|
• 24 of 30 mutants develop pancreatic ductal adenocarcinomas
|


Analysis Tools